Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort

Abstract Background Blood-based Alzheimer’s disease (AD) biomarkers have been increasingly employed for diagnostic, prognostic, and therapeutic monitoring purposes, due to accuracy in distinguishing AD pathophysiologic process. Compared to other p-tau isoforms, plasma p-tau217 exhibits stronger asso...

Descripció completa

Dades bibliogràfiques

Autors principals:	Neetesh Pandey, Zikun Yang, Basilio Cieza, Dolly Reyes-Dumeyer, Min Suk Kang, Rosa Montesinos, Marcio Soto-Añari, Nilton Custodio, Lawrence S. Honig, Giuseppe Tosto
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-01-01
Col·lecció:	Alzheimer’s Research & Therapy
Matèries:	Alzheimer’s disease Plasma biomarker P-tau217 Plasma APOE
Accés en línia:	https://doi.org/10.1186/s13195-024-01655-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!